Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic Leukemia
- 7 Downloads
Acute lymphoblastic leukemia (ALL) accounts for 20% of all adult leukemias and is the most common leukemia during childhood (80%). We present data on cytogenetics of ALL from a tertiary centre in India correlating it with clinical factors. Karyotyping of bone marrow samples of 204 patients with newly diagnosed ALL was performed with standard G-banding technique. Clinical data of patients was obtained from case records. Survival was estimated using Kaplan–Meir curves and compared by the log-rank test. Univariate and multivariate analysis was done for survival with age, sex, immunophenotype, hyperleukocytosis, risk type, remission status and cytogenetics. The most common karyotypes observed were normal in 39.7% (N = 81), hyperdiploidy in 12.7% (N = 26), t(9;22) in 4.4% (N = 9), t(1;19) in 3.9% (N = 8). Adults with ALL had worse survival compared with pediatric patients (HR 3.62; 2.03–6.45 95% CI, p < 0.001). Patients not in morphologic remission after induction chemotherapy fared poorly (HR 4.86; 2.67–8.84 95% CI, p < 0.001). Patients with favourable cytogenetics had better overall survival (HR 0.36; 0.12–1.05 95% CI, p < 0.05). On multivariate analysis, achievement of morphologic remission emerged as single most significant predictor of survival (p < 0.001). MLL gene rearrangement and t(12;21) were seen less commonly as compared to Western data. However, incidence rates of various cytogenetic abnormalities were similar to that reported from other centres from India. Age, morphologic remission at end of induction chemotherapy and favourable cytogenetics correlated significantly with survival.
KeywordsAcute lymphoblastic leukemia Cytogenetics Karyotype India Overall survival
Compliance with Ethical Standards
This is a retrospective study. According to institutional policies ethical committee approval is not required for such studies.
Conflict of interest
The authors declare that they have no conflict of interest.
- 6.Faderl S, Kantarjian HM, Talpaz M, Estrov Z (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91(11):3995–4019Google Scholar
- 8.Moorman AV, Harrison CJ, Buck GAN, Richards SM, Secker-Walker LM, Martineau M et al (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109(8):3189–3197CrossRefGoogle Scholar
- 9.Wetzler M, Dodge RK, Mrózek K, Carroll AJ, Tantravahi R, Block AW et al (1999) Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia group B experience. Blood 93(11):3983–3993Google Scholar
- 10.Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE et al (2010) Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol 11(5):429–438CrossRefGoogle Scholar
- 13.Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML et al (1995) TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9(12):1985–1989Google Scholar
- 18.Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3):163–170Google Scholar
- 20.Griffin TC, Tomlinson GE, Raimondi SC, Sandoval C, Timmons CF, Rosenfield C et al (1992) Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22). Leukemia 6(6):535–540Google Scholar
- 21.Aliano S, Cirmena G, Fugazza G, Bruzzone R, Palermo C, Sessarego M (2013) Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy. Leuk Res Rep 2(2):75–78Google Scholar
- 24.Mazloumi SHM, Madhumathi DS, Appaji L, Prasannakumari null (2012) Combined study of cytogenetics and fluorescence in situ hybridization (FISH) analysis in childhood acute lymphoblastic leukemia (ALL) in a tertiary cancer centre in South India. Asian Pac J Cancer Prev 13(8):3825–3827CrossRefGoogle Scholar
- 30.Othman MAK, Rincic M, Melo JB, Carreira IM, Alhourani E, Hunstig F et al (2014) A novel cryptic three-way translocation t(2;9;18)(p23.2;p21.3;q21.33) with deletion of tumor suppressor genes in 9p21.3 and 13q14 in a T-cell acute lymphoblastic leukemia. Leuk Res Treat 2014:357123Google Scholar